Several painkillers have been banned due to safety concerns or specific restrictions on their use. These include Rofecoxib, Valdecoxib, and Diclofenac and its formulations for animal use.
The regulation of pharmaceutical drugs is crucial for public safety, leading to the prohibition of certain medications found to pose significant risks. This ensures that only safe and effective treatments are available.
Banned Painkillers and Their Details
The following table outlines specific painkillers that have been banned, along with the details of their prohibition:
| Painkiller | Type | Notification of Ban |
|---|---|---|
| Rofecoxib | NSAID (Non-Steroidal Anti-Inflammatory Drug) | GSR 810(E) dt. 13.12.04 |
| Valdecoxib and its formulation | NSAID (Non-Steroidal Anti-Inflammatory Drug) | GSR 510(E) dt. 25.07.05 |
| Diclofenac and its formulations for animal use | NSAID (Non-Steroidal Anti-Inflammatory Drug) | GSR 499(E) dt. 4.07.08 |
- Rofecoxib and Valdecoxib are both COX-2 selective NSAIDs that were widely used for pain and inflammation. However, they were withdrawn from the market due to concerns about increased risks of cardiovascular events, such as heart attacks and strokes.
- Diclofenac is a common NSAID, but its formulations for animal use have been banned in certain contexts. This specific ban often relates to its devastating impact on vulture populations that feed on the carcasses of livestock treated with the drug. This environmental concern led to its prohibition for animal treatment in many regions to protect wildlife.
Understanding which medications are prohibited and the reasons behind these bans is essential for both healthcare professionals and the general public to ensure safe and responsible drug use.
